U. Briner
-
- Growth Hormone and Insulin-like Growth Factors 8
- Pituitary Gland Disorders and Treatments 6
- Epidemiology top 2%
- Neuroendocrine Tumor Research Advances 12
- Neurology top 2%
- Neuroblastoma Research and Treatments 2
- Oncology top 5%
-
- Chemical synthesis and alkaloids 5
-
- Glycosylation and Glycoproteins Research 4
- Chemical Synthesis and Analysis 2
-
- Plant and fungal interactions 2
U. Briner
23 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Endocrinology, Diabetes and Metabolism 868
- Epidemiology 1.2k
- Neurology 468
- Oncology 587
- Radiology, Nuclear Medicine and Imaging 273
Countries citing papers authored by U. Briner
This map shows the geographic impact of U. Briner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Briner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Briner more than expected).
Fields of papers citing papers by U. Briner
This network shows the impact of papers produced by U. Briner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Briner. The network helps show where U. Briner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside U. Briner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 5 | |
| 2 | SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profilebreakdown → | 2002 | 555 |
| 3 | 1998 | 23 | |
| 4 | 1996 | 59 | |
| 5 | Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995. | 1996 | 8 |
| 6 | 1993 | 17 | |
| 7 | 1993 | 63 | |
| 8 | 1992 | 34 | |
| 9 | 1992 | 13 | |
| 10 | 1991 | 41 | |
| 11 | 1988 | 12 | |
| 12 | 1988 | 9 | |
| 13 | 1988 | 28 | |
| 14 | 1987 | 10 | |
| 15 | 1986 | 1 | |
| 16 | 1984 | 4 | |
| 17 | 1979 | 25 | |
| 18 | 1978 | 11 | |
| 19 | Inhibition of gastric secretion and ulcer formation with synthetic salmon calcitonin in animal experiments. | 1977 | 1 |
| 20 | 1975 | 2 |
About U. Briner
U. Briner is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology, Organic Chemistry, Biochemistry and Neurology, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (12 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Pituitary Gland Disorders and Treatments (6 papers), Chemical synthesis and alkaloids (5 papers), Glycosylation and Glycoproteins Research (4 papers), Chemical Synthesis and Analysis (2 papers), Neuroblastoma Research and Treatments (2 papers) and Plant and fungal interactions (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (868 citations), Epidemiology (1.2k citations), Neurology (468 citations), Oncology (587 citations) and Radiology, Nuclear Medicine and Imaging (273 citations). U. Briner has collaborated with scholars based in Switzerland, Japan and United States. Frequent co-authors include Peter Marbach, W. Doepfner, W. Bauer, Christian Bruns, Gisbert Weckbecker, Trevor J. Petcher, Ian Lewis, Janos Pless, R Huguenin and Guy Meno‐Tetang. Their work appears in journals such as Cellular and Molecular Life Sciences, Life Sciences, Digestion, Scandinavian Journal of Gastroenterology and Clinical Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.